ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
AZZAS 2154

AZZAS 2154 (AZZA3M)

31.45
0.00
(0.00%)
마감 23 1월 5:55AM

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

주요 통계 및 세부정보

가격
31.45
매수가
0.00
매도가
0.00
거래량
5,747,600
0.00 일간 변동폭 0.00
51.89 52주 범위 51.89
전일 종가
31.45
개장가
-
최근 거래 시간
2873800
마지막 거래 시간
평균 볼륨(3m)
-
재정 규모
-
VWAP
-

AZZA3M 최신 뉴스

No news to show yet.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
40000000CS
120000000CS
26-20.44-39.391019464351.8951.8951.8900CS
52-20.44-39.391019464351.8951.8951.8900CS
156-20.44-39.391019464351.8951.8951.8900CS
260-20.44-39.391019464351.8951.8951.8900CS

AZZA3M - Frequently Asked Questions (FAQ)

What is the current AZZAS 2154 ON share price?
The current share price of AZZAS 2154 ON is R$ 31.45
What is the 1 year trading range for AZZAS 2154 ON share price?
AZZAS 2154 ON has traded in the range of R$ 51.89 to R$ 51.89 during the past year

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ZAMP3Zamp S.A.
R$ 2.94
(14.40%)
992.1k
OPCT3Oceanpact Servicos Maritimos S.A
R$ 5.59
(12.93%)
4.56M
AZEV11Azevedo Travassos Sa
R$ 0.29
(11.54%)
28.7k
ONCO3Oncoclinicas Brasil Servicos Medico
R$ 2.22
(8.82%)
11.99M
AZUL4AZUL SA
R$ 4.60
(6.98%)
24.08M
AMAR11Lojas Marisa S.A.
R$ 0.47
(-14.55%)
3.2k
BSLI4Banco De Brasilia SA
R$ 7.20
(-9.32%)
600
PGMN11Empreendimentos Pague Menos S.A.
R$ 0.51
(-8.93%)
14.5k
RCSL3Recrusul Sa
R$ 4.20
(-8.89%)
4.66M
OIBR4Oi
R$ 8.61
(-8.60%)
86.3k
HAPV3Hapvida Participacoes Investimento SA
R$ 2.31
(1.32%)
55.24M
ABEV3Ambev SA
R$ 11.02
(-2.04%)
44.99M
BBDC4Bco Bradesco Sa
R$ 11.48
(-1.37%)
42.53M
VALE3Vale SA
R$ 52.66
(-2.52%)
34.65M
CVCB3CVC Brasil Operadora E Agencia De Viagens SA
R$ 1.84
(6.36%)
32.57M
boarddork boarddork 5 분 전
That’s a lot of push pins and zig zag strings to make that ultimate conclusion.
COOP
weedtrader420 weedtrader420 5 분 전
BITCOIN XRP TRIUMPH MAGIC POWER $120,000 TARGET
BTCUSD
janice shell janice shell 6 분 전
She's one of the very few who actually deserves a pardon.
Hoskuld Hoskuld 7 분 전
This is not really true Boi - although I can imagine that logically it should be true. But, no 2 companies run their trials the same way. Usually. this is deliberate. The FDA cannot evaluate them the same way, as a result. The guidelines are NOT requirements. They are simply suggestions.
AVXL
StayHumble StayHumble 7 분 전
wow💹100% Xpert SHORT interest💹significant evidence of SHORTS💹💹 huzzah!!!
HMBL
WALL STREET KID WALL STREET KID 8 분 전
$AMC 5B SWAPS EXPIRING! SHORTS AT RISK! Short Squeeze Update

https://youtu.be/eUD6PpQ-Oxw?si=QpOWsGLt0b2Qu2s6
AMC
vinmantoo vinmantoo 10 분 전
Jq1234, give Bluesky a try. It looks a lot like Twitter did but doesn’t have a controlling algorithm.
WhAtEvA1 WhAtEvA1 11 분 전
With 18 indications trial starting in India well ahead of US trials (and if proven successful) it won't take long when Vivos valuations will be trading forward. IMHO of course. It is worth bios do when efficacy data is strong and potential of approval in the public interest outweighs the risks.
RDGL
glens0 glens0 11 분 전
$CTOR Not to many shares left in the market. Should go up real fast when good news comes out. And it should be soon.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
Zorch305 Zorch305 12 분 전
Whats 305
RNVA
theorysuit theorysuit 14 분 전
You keep pointing to this journal as if that leads to approval. I think i told you this, this journal was meant to explain this garbage trial.....Pointing to the scoreboard. Any approvals? Over 20 years since this trial was started, 6 years since it has ended, and 4.5 years since data lock. NO
NWBO
WHITTENHALLJR WHITTENHALLJR 14 분 전
Yes I bet it 2x better then before strap in stock-nuts
CLHI
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 14 분 전
Anavex Life Sciences Corp. AVXL: This clinical stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.8% over the last 60 days. Anavex’s shares gained 63.3% over the last three months compared with the S&P 500’s adva
AVXL
GUNSMOKE GUNSMOKE 15 분 전
https://www.otcmarkets.com/filing/html?id=18121280&guid=sJ0-kqxrs0Hhh3h
ASST
band aid band aid 15 분 전
Bobby, he or she is saying that this is a PIG. I wish you good luck here and I hope you hit it out of the park. As for me I took a huge pounding on this trash but still hold a small position just in case the sky falls out of the universe and this PIG could figure out a way to sell some of their jun
BIEL
glens0 glens0 16 분 전
CTOR Not to many shares left in the market. Should go up real fast when good news comes out.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
NoMoDo NoMoDo 17 분 전
Done. He is an amazing boy. Nuclear engineer.
HMBL
Acme Investments Acme Investments 17 분 전
👇 When he comes through it will be something else for you clowns to talk about!! Sitting around counting days is Sad!!
BCAP
Whalatane Whalatane 17 분 전
Recent Open Market purchases by the Chairman of the Board ...David Mott
On December 19, 2024, Mott purchased 213,300 shares at an average price of $4.6722, for a total amount of $996,58034.
On November 13, 2024, he bought 215,868 shares at an average price of $4.6167, totaling $996,59
ARDX

최근 히스토리

Delayed Upgrade Clock